Background: Photodynamic therapy (PDT) is a less invasive cancer treatment using photochemical reactions induced by light irradiation to a photosensitizer (PS). Highly selective PDT with fast accumulation of the PS in target site might be a promising treatment option for drug-resistant prostate cancer facing high incidence rate of elderly men who have no effective treatment options and require a minimally invasive treatment. Hemagglutinating virus of Japan envelope (HVJ-E) allows selective and fast drug delivery to the drugresistant prostate cancer cells via rapid cell membrane fusion. PS named porphyrus envelope (PE) has been developed by insertion of lipidated protoporphyrin IX (PpIX lipid) into HVJ-E. In this study, we investigated the optimal conditions for PE preparation and laser irradiation for highly selective PDT using PE with a short drug-light interval. Materials and Methods: Human hormon refractory prostate cancer cell line PC-3 and human normal prostate epithelial cell line PNT2 were cultured. PpIX lipid uptake and cytotoxicity of PDT in the cells incubated with PE for 10 min were evaluated by measuring fluorescence intensity and by using a cell counting reagent 24 h after PDT, respectively. Results: PpIX lipid uptake and cytotoxicity of PDT were increased with PpIX lipid concentration. Cytotoxicity of PDT using PE was more than 9 times as strong as that with PpIX lipid and PpIX induced by 5-aminolevulinic acid. Much stronger cytotoxicity was induced in PC-3 cells than PNT2 cells with the ratio of cell death rate for cancer to normal cells up to 4.64 ± 0.09. Conclusions: Fast PS delivery with HVJ-E allows highly selective PDT with a short drug-light interval. Therefore, PDT using PE has a potential to shorten treatment period and reduce side effects of PDT.
Introduction
Prostate cancer is becoming the most common cancer due to the aging population [1] . Hormone therapy has been considered as an effective treatment since prostate cancer grows with androgen. However, cancer cells often become resistant to the therapy [2] , and disease progress requires that patients undergo chemotherapy whose response rate is not high enough to radically cure such drugresistant prostate cancer [3] .
Photodynamic therapy (PDT) is a cancer treatment using photochemical reactions induced by light irradiation to a photosensitizer (PS). The PS is excited by a specific wavelength of light and reacts with surrounding substrates or oxygen to produce reactive oxygen species (ROS) that damages tissues where the PS is localized [4] . Unlike an anticancer drug, the PS alone exhibits no severe cell toxicity [5] , and low power light irradiation allows patients to obtain therapeutic efficacy after repeated treatment [6] . These characteristics of drugs and laser irradiation suggest that PDT is a potential treatment for drug-resistant prostate cancer [7] [8] [9] . Selectivity in therapeutic efficacy of conventional PDT is mainly related to the selective accumulation of the PS in tumor tissue or neovasculature. In reality, however, the PS itself has poor selectivity, leading to the long interval lasting from administration of the PS to light irradiation for maximization of the gap of PS concentration in between tumor and normal tissue. This interval is known as "drug-light interval" and patients need to stay out sun and room light for 3 -48 h [10] . Poor selectivity of PSs is also associated with side effects such as normal tissue damage and skin photosensitivity after treatment. Especially, photosensitivity results in prolong light shielding period for 1 -4 weeks that increases treatment cost and makes patients feel uncomfortable about the therapy [11] [12] .
To overcome these problems in clinical, a number of site-specific delivery of the PS has been received much attention. Replication-defective hemagglutinating virus of Japan (HVJ) envelope (HVJ-E) particle is considered to be a safe and effective carrier of DNA, proteins and drugs [13] [14] to a target cell. HVJ-E introduces those contents in cells thorough membrane fusion process via two types of viral proteins on its surface called hemagglutinin-neuraminidase (HN) and fusion (F) protein [15] . HN protein binds to its receptor gangliosides on International Journal of Clinical Medicine host cell membrane, and then F protein-mediated membrane fusion occurs [16] . HVJ-E has two characteristics suitable as a carrier of the PS to drug-resistant prostate cancer cells. First, receptors of HN protein are more expressed in human drug-resistant prostate cancer cell lines PC-3 and DU145 compared with the normal prostate epithelial cell line PNT2 [17] . This cancer-specific expression of receptors enables HVJ-E to selectively deliver the PS to such prostate cancer cells. Second, membrane fusion takes place immediately after the adsorption of HVJ-E to the cells within a few minutes [18] , and localization of the PS in the cell membrane significantly enhances therapeutic efficacy of PDT by inducing substantial membrane disruption upon laser irradiation even at a low PS concentration [19] . Taken together, rapid membrane fusion has a possibility to induce strong cytotoxicity in cancer cells at a short drug-light interval.
These characteristics of HVJ-E suggest that delivery of the PS by HVJ-E induces selective cytotoxicity of PDT in drug-resistant prostate cancer at a short drug-light interval. We have previously developed a PS named porphyrus envelope (PE) by insertion of lipidated protoporphyrin IX (PpIX lipid) into HVJ-E [20] [21] . Previous study showed that PE undergoes membrane fusion with PC-3 cells by 10 min incubation [22] and PpIX lipid localizes in the cell membrane [23] . However, the optimal conditions for PE preparation and light irradiation for PDT with a short drug-light interval have not been clarified and selectivity in PDT using PE remains unclear. In this study, we examined uptake kinetics of PE-mediated PpIX lipid and cytotoxicity of PDT in both PC-3 and PNT2 cells with the 10 min drug-light interval in order to determine the optimal concentration of PpIX lipid loaded in PE and light irradiation energy density for highly selective PDT against drug-resistant prostate cancer cells.
Materials and Methods

Cell Culture
Hormone refractory human prostate cancer cell line PC-3 and human normal prostate epithelial cell line PNT2 were purchased from the American Type Culture Collection (USA), respectively. The cell lines were cultured in Dulbecco's modified Eagle's medium (D6046, Sigma-Aldrich, USA) with fetal bovine serum (S1820, Biowest, France) and 100 units/mL penicillin-streptomycin (P4458, Sigma-Aldrich). The cells were incubated at 37˚C humidified atmosphere containing 5% CO 2 . PC-3 and PNT2 cells were reseeded after reaching confluence of 80% and 70%, respectively. with ratios of the amount of PpIX lipid to titer of HVJ-E for 0 -9.65 pmol/HAU.
Photosensitizers
After centrifugation, PE was prepared by suspending the pellet in 833 µL of the culture medium. In all the experiments, the culture medium and PSs were administrated to the cells at a dose of 50 µL.
Light Source and Optical Setup
A laser diode (VLM 500, Sumitomo Electric Industries, Japan) emitting continuous wave light with a wavelength of 405 nm was used as a light source. The wavelength corresponds to the highest absorption peak of PE [21] Laser light with a wavelength of 405 nm was guided by an optical fiber, was collimated to a diameter of 6.6 mm, and was irradiated to a clear bottom of a 96-well cell culture plate with a black wall.
Dependence of PS Uptake and PDT Efficacy in PC-3 Cells on
The distance between the tip of the fiber and a bottom of the cell culture plate was vertically adjusted to 90 mm. The position of the plate was controlled by a two-axis motorized linear stage and the temperature of the plate was maintained at 37˚C using a plate warmer.
cell lysate was measured by a fluorescence microplate reader (SpectraMAX Gemini, Molecular Devices, USA) at excitation and fluorescence wavelengths of 401 nm and 625 nm, respectively.
PDT Procedure
PC-3 cells were incubated as described above. PpIX lipid loaded in PE was prepared to the concentration range of 1.75 -9.5 pmol/HAU. Subsequently, the cells were washed with 100 µL of D-PBS and a 100 µL of the fresh culture medium was added to the cells. Immediately after addition of the medium, cells were irradiated using a laser light for 60 s at an energy density of 6 J/cm 2 .
Comparison of PDT Efficacy of PE with That of PpIX Lipid
Alone and 5-ALA-Induced PpIX PC-3 cells were incubated as described above, and incubated with the culture medium, PpIX lipid, 5-ALA solution, or PE suspension with 9.5 pmol/HAU PpIX lipid for 10 min, 30 min, 1 h, or 2 h. Subsequently, the cells were washed with D-PBS, and the fresh culture medium was added. Then laser light was irradiated as described above. 
Evaluation of
Cell Survival Assay
Cells irradiated with a laser light were incubated at 37˚C containing 5% CO 2 for 24 h, and the culture medium in each well was replaced with the mixture of 100 µL of the fresh culture medium and 10 µL of a cell counting reagent (07553-44, NacalaiTesque, Japan) containing water-soluble tetrazolium salt (WST-8). Cells were further incubated for 1 h, and the optical density (OD) of the culture medium containing formazan dye produced upon reduction of WST-8 by dehydrogenases in a living cell was measured at a wavelength of 450 nm using an absorbance microplate reader (VersaMAX, Molecular Devices). Cell survival rate was defined as the ratio of OD of the cells exposed to the PS and laser light, to that of the cells which were exposed to laser light only.
Statistical Analysis
Statistical analysis was conducted using a two-tailed unpaired Student's t-test for detecting the significant difference between two samples and probability values of P < 0.05 were considered to indicate statistical significance.
Results
PpIX Lipid Uptake and Cytotoxicity of PDT Increased with PpIX Lipid Concentration in PE
To determine the PpIX lipid concentration required for PDT using PE with the 10 min drug-light interval against PC-3 cells, the amount of PpIX lipid and cytotoxicity of PDT were assessed using PE with different PpIX lipid concentrations. Concentration-dependent PpIX lipid uptake was observed at PpIX lipid concentration higher than 1.21 pmol/HAU (Figure 2 
PDT Using PE Induced Much Stronger Photo-Cytotoxicity than That of Other PpIX-Mediated PDT
To confirm whether PDT using PE could induce stronger photo-cytotoxicity at the 10 min drug-light interval than that of other PpIX-mediated PDT, PC-3 cells were incubated with the culture medium, PE, PpIX lipid alone, or 5-ALA which is metabolized into PpIX in a cellular mitochondria. At the 10 min drug-light interval, survival rates of PC-3 cells incubated with PpIX lipid alone and 5-ALA were 100% and 90%, respectively, and the rates decreased with the increase of drug-light interval, while survival rate of the cells incubated with PE was lower than 10%, and time-dependent decrease in cell survival rate was hardly observed in the drug-light interval of between 10 min and 2 h (Figure 3 ).
PE Allowed Selective Delivery of PpIX Lipid Even at a Short Incubation Period
To examine the selectivity for uptake kinetics of PpIX lipid, the amounts of PpIX The data represent the mean ± standard deviation. *, significance at P < 0.05.
PE-Mediated PDT Induces Highly Selective Cytotoxicity with a Short Drug-Light Interval
To determine doses of PpIX lipid and laser light which are required for highly selective PDT using PE with a short drug-light interval, the cytotoxicity of PDT in PC-3 and PNT2 cells were assessed using PE with different PpIX lipid con- (Table 1 ).
Discussion
As shown in Figure 4 , PE showed the selective uptake in all PpIX lipid concentrations and incubation periods, and distinct time-dependent increases in selectivity were hardly observed. We consider that rapid and cancer-selective PS delivery by HVJ-E allowed selective accumulation of the PS even at a short incubation period [24] [25] . Based on this, we performed PDT using PE with high con- In this study, we also evaluated the selectivity of cell death induced by PDT using PE with the 10 min drug-light interval. As shown in Table 1 , T/N ratio of cell death in PDT was higher than that of PE uptake. It is known that selective apoptosis in PC-3 cells but not in PNT2 cells is induced via recognition of fragmented HVJ-E's RNA genome by intracellular retinoic acid-inducible gene-I whose signaling pathway selectively activates apoptosis-inducing ligands in PC-3 cells [26] . In this study, survival rates of PC-3 cells were lower than those of , respectively. The data represent the mean ± standard deviation. Table 1 . T/N ratio of cell death in PDT using PE with the 10 min drug-light interval under different PpIX lipid concentrations and irradiation energy densities. The ratio was calculated by division of the cell death rate for PC-3 cells to PNT2 cells based using the cell survival rates shown in Figure 5 . Laser irradiation at energy densities of 18 J/cm 2 PC-3 cells but not in PNT2 cells, and the cytotoxicity was maintained even after PE had been subjected to laser light at an energy density of 6 J/cm 2 with the same light source and power density, as described in this study [23] . Other study reported that there was threshold of cellular PpIX amount for cell killing and T/N ratio of cellular PpIX uptake did not strictly correspond to that of cell death [27] .
In this study, when PNT2 cells were incubated with PE at PpIX lipid concentra- . Furthermore, tumor-specific PS delivery is known to be a promising strategy to further improve the accumulation efficacy and retention of the PS which is directly administrated into tumor tissue [34] [35] . Therefore, the possibility of intratumoral administration of PE in vivo trials probably provides higher selectivity in PDT with a short drug-light interval than in vitro experiments, as reported in this study.
Conclusion
In this study, we focused on the fast delivery of the PS by HVJ-E and have demonstrated highly selective cytotoxicity of in vitro PDT using PE against drug-resistant prostate cancer cells with a short drug-light interval. This result suggests that PE-mediated PDT can shorten drug-light interval and reduce PDT-mediated side effects, and gives the possibility to apply PDT to a novel treatment modality for drug-resistant prostate cancer in clinical.
